Some side effects include gastrointestinal issues, dehydration, electrolyte abnormalities, loss of muscle mass and cardiovascular effects such as increased heart rate
The FDA prescribing information for Vyleesi provides clinicians and patients with precisely characterized cardiovascular effects (peak systolic elevation of ~6 mmHg at 24 hours post-dose, returning to baseline within 12 hours), documented contraindications (uncontrolled hypertension, known cardiovascular disease), and management strategies for nausea (ondansetron 30 minutes pre-dose)
Oral Semaglutide Side Effects As with all medications, oral semaglutide can cause side effects, though most are mild to moderate and tend to improve over time
The combination of prescription medications, medical supervision, and personalized support creates a powerful framework for achieving your weight loss goals
The Semaglutide Patent Landscape in 2026: A Country-by-Country Picture Semaglutide is protected not by one patent but by a patent thicket a layered portfolio of patents covering the molecule itself, formulation, delivery device, and dosing method